Literature DB >> 17253860

E/Z-rubrolide O, an anti-inflammatory halogenated furanone from the New Zealand ascidian Synoicum n. sp.

A Norrie Pearce1, Elizabeth W Chia, Michael V Berridge, Elizabeth W Maas, Michael J Page, Victoria L Webb, Jacquie L Harper, Brent R Copp.   

Abstract

Bioassay-directed fractionation of extracts of a Synoicum n. sp. ascidian from New Zealand led to the isolation of the principal anti-inflammatory component, which was identified by spectroscopic methods as a new member of the rubrolide family, rubrolide O (1), existing as a mixture of E/Z isomers.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17253860     DOI： 10.1021/np060188l

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  9 in total

1.  Antimicrobial rubrolides from a South African species of Synoicum tunicate.

Authors:  Justyna Sikorska; Shirley Parker-Nance; Michael T Davies-Coleman; Oliver B Vining; Aleksandra E Sikora; Kerry L McPhail
Journal:  J Nat Prod       Date:  2012-10-02       Impact factor: 4.050

2.  Molecular Insight into Gene Response of Diorcinol- and Rubrolide-Treated Biofilms of the Emerging Pathogen Stenotrophomonas maltophilia.

Authors:  Mirja Gudzuhn; Ifey Alio; Raphael Moll; Jessica de Vries; Jacob Boehlich; Maik Assmann; Jasmin Janneschütz; Nina Schützenmeister; Axel Himmelbach; Anja Poehlein; Rolf Daniel; Wolfgang R Streit
Journal:  Microbiol Spectr       Date:  2022-04-26

3.  Expanding the chemical diversity of an endophytic fungus Bulgaria inquinans, an ascomycete associated with mistletoe, through an OSMAC approach.

Authors:  Ni P Ariantari; Georgios Daletos; Attila Mándi; Tibor Kurtán; Werner E G Müller; Wenhan Lin; Elena Ancheeva; Peter Proksch
Journal:  RSC Adv       Date:  2019-08-13       Impact factor: 3.361

4.  Marine Bromophenol Derivative 3,4-Dibromo-5-(2-bromo-3,4-dihydroxy-6-isopropoxymethyl benzyl)benzene-1,2-diol Protects Hepatocytes from Lipid-Induced Cell Damage and Insulin Resistance via PTP1B Inhibition.

Authors:  Jiao Luo; Ning Wu; Bo Jiang; Lijun Wang; Shuaiyu Wang; Xiangqian Li; Baocheng Wang; Changhui Wang; Dayong Shi
Journal:  Mar Drugs       Date:  2015-07-17       Impact factor: 5.118

Review 5.  Marine invertebrate natural products for anti-inflammatory and chronic diseases.

Authors:  Kalimuthu Senthilkumar; Se-Kwon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-31       Impact factor: 2.629

Review 6.  Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.

Authors:  Satheesh Kumar Palanisamy; N M Rajendran; Angela Marino
Journal:  Nat Prod Bioprospect       Date:  2017-01-17

Review 7.  Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Nobuhiro Fusetani
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2010-09-15       Impact factor: 3.228

8.  Targeted Isolation of Rubrolides from the New Zealand Marine Tunicate Synoicum kuranui.

Authors:  Joe Bracegirdle; Luke J Stevenson; Michael J Page; Jeremy G Owen; Robert A Keyzers
Journal:  Mar Drugs       Date:  2020-06-27       Impact factor: 5.118

9.  Synthesis and Biological Evaluation of Analogues of Butyrolactone I as PTP1B Inhibitors.

Authors:  Bihong Hong; Jianlin He; Chaochun Fan; Chao Tang; Qingqing Le; Kaikai Bai; Siwen Niu; Meitian Xiao
Journal:  Mar Drugs       Date:  2020-10-23       Impact factor: 5.118
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.